You are here

Kadcyla

SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla

Fierce Pharma

Fri, 12/9/22 - 10:54 am

Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country

Endpoints

Thu, 01/23/20 - 12:11 pm

antibody-drug conjugate

Roche's breast cancer hopes get a boost from post-surgery Kadcyla approval

Fierce Pharma

Mon, 05/6/19 - 11:46 am

HER-2 postive breast cancer

Roche seeks FDA approval for Kadcyla in HER2-positive early breast cancer

Pharmaceutical Business Review

Tue, 02/5/19 - 10:18 am

HER2-positive early breast cancer

Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could help

Fierce Pharma

Mon, 10/15/18 - 11:47 pm

BRCA-mutant breast cancer

A Look at Roche’s Potential Revenue Drivers

Market Realist

Tue, 07/26/16 - 11:21 am

Inside Roche’s Next Oncology Portfolio Drivers

Yahoo/Market Realist

Mon, 03/28/16 - 08:42 am

T-DM1. breast cancer

ImmunoGen, Roche gastric cancer drug fails study

Yahoo/Reuters

Thu, 10/22/15 - 09:54 am

clinical trials

Large U.S. cancer trial to match genetic glitches to targeted drugs

Yahoo/Reuters

Mon, 06/1/15 - 07:49 pm

clinical trials

Boehringer Ingelheim

personalized medicine

Roche's Double Drug Failure Is Meaningful

Seeking Alpha

Fri, 12/26/14 - 10:19 pm

Double blow for Roche as breast cancer, Alzheimer's studies fail

Yahoo/Reuters

Fri, 12/19/14 - 08:29 am

Alzheimer's disease

Roche Rebuked by U.K. on $152,850 Breast Cancer Drug

Bloomberg

Fri, 08/8/14 - 08:44 am

Roche's breast cancer franchise keeps delivering, with huge jumps for Perjeta, Kadcyla

Fierce Pharma

Fri, 07/25/14 - 09:18 am

Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land

Fierce Pharma Marketing

Thu, 06/26/14 - 10:21 am

Breo Ellipta and Anoro Ellipta

Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave

Fierce Pharma Marketing

Thu, 05/8/14 - 12:30 pm

NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations

Fierce Pharma

Wed, 04/23/14 - 12:02 pm

HER2-positive metastatic breast cancer

PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative

Seeking Alpha

Tue, 02/4/14 - 09:58 am

Lucentis Xolair

PDL Biopharma says it settled Roche royalty fight

Yahoo/AP

Mon, 02/3/14 - 03:58 pm

EU backs Roche’s Kadycla in breast cancer

PM Live

Wed, 11/20/13 - 08:33 am

7 Disruptive Drugs for the Next Decade

Motley Fool

Wed, 10/9/13 - 10:42 pm

Bristol-Myers Squibb

Lexicon Pharmaceuticals

Pages